ITOC logo

ITONIC HOLDINGS LTD

ITOCNASDAQ
πŸ† #3858 by market capUS Equity
$0.29β–² $0.00 (+0.62%)
Live
1hβ€”
24hβ–² 0.6%
7dβ–² 6.1%
14dβ–² 16.0%
30dβ–Ό 8.2%
1yβ–Ό 97.4%
🏦Market Cap
$34M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+16.7%
Healthy
πŸ“ŠGross Margin
62.6%
High
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
9.4x
Elevated
Otter Score
52
Weak

Trading Snapshot

Day Range
$0.29 – $0.29
52-Week Range
$0.22 – $1.18
Volume
$2.81B
Avg Volume
$3.53B
Shares Outstanding
117.0M
Next Earnings
Sep 21, 2026

Fundamentals Snapshot

Annual Revenue
$523,031
Last Q Revenue
$455,524
P/E Ratio
β€”
P/S Ratio
9.4x
EPS (TTM)
$-0.32
Dividend Yield
β€”

Why Investors Own ITOC

  • βœ“High-growth profile β€” revenue up +4.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 43% gross margin and 22% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$523,031β–² +2.5% YoY
Gross Margin (TTM)
42.8%β–² +0.5% YoY
Operating Income (TTM)
$172,600β–² +2.5% YoY
Free Cash Flow (TTM)
$114,544β–² +2.5% YoY

About ITONIC HOLDINGS LTD

iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients. Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
52/100

Analyst Price Target

β“˜
Average Target
$0.28
β–Ό βˆ’2.1% Downside
High Target$0.32
Low Target$0.25
Based on 16 analysts

Latest News & Updates